To analyze whether MACC1-AS1-mediated MACC1 upregulation resulted from mRNA stability, we treated breast cancer cell lines with actinomycin D (5 μg/mL) for 24 h to block de novo transcription and measured the endogenous levels of MACC1 mRNA by RT-qPCR. The gene discussed is MACC1; the disease is breast cancer.